Thorne HealthTech (THRN) Stock Price, News & Analysis

Company Overview

Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.

Key Stats

• Today's Range: $10.19 to $10.19
• 50-Day Range: $10.13 to $10.20
• 52-Week Range: $3.41 to $10.20
• Volume: N/A
• Average Volume: 110,986 shs
• Market Capitalization: $549.44 million
• P/E Ratio: 26.82
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

THRN Stock Analysis - Frequently Asked Questions

How were Thorne HealthTech's earnings last quarter?

Thorne HealthTech, Inc. (NASDAQ:THRN) announced its earnings results on Wednesday, November, 10th. The company reported $0.01 EPS for the quarter, beating analysts' consensus estimates of ($0.02) by $0.03. The business earned $48.01 million during the quarter. Thorne HealthTech had a net margin of 7.84% and a trailing twelve-month return on equity of 9.03%.

When did Thorne HealthTech IPO?

Thorne HealthTech (THRN) raised $98 million in an initial public offering on Thursday, September 23rd 2021. The company issued 7,000,000 shares at $13.00-$15.00 per share.

What other stocks do shareholders of Thorne HealthTech own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Thorne HealthTech investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), e.l.f. Beauty (ELF), Arista Networks (ANET), Disc Medicine (IRON) and Jabil (JBL).

Company Calendar

• Last Earnings: 11/10/2021
• Today: 5/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Defensive
• Industry: Packaged Foods
• Sub-Industry: N/A
• Current Symbol: NASDAQ:THRN
• CIK: 1844280
• Web: www.thorne.com
• Phone: 929-251-6321
• Fax: N/A
• Employees: 544
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.38
• Trailing P/E Ratio: 26.82
• Forward P/E Ratio: 35.14
• P/E Growth: N/A
• Net Income: $15.67 million
• Net Margins: 7.84%
• Pretax Margin: 5.59%
• Return on Equity: 9.03%
• Return on Assets: 5.57%

Debt

• Debt-to-Equity Ratio: 0.16
• Current Ratio: 2.41
• Quick Ratio: 1.13

Sales & Book Value

• Annual Sales: $228.73 million
• Price / Sales: 2.40
• Cash Flow: $0.26 per share
• Price / Cash Flow: 39.41
• Book Value: $2.78 per share
• Price / Book: 3.67

Miscellaneous

• Outstanding Shares: 53,920,000
• Free Float: 13,480,000
• Market Cap: $549.44 million
• Optionable: Optionable
• Beta: 0.82